Peptides for treating axonal damage, inhibition of neurotransmitter release and pain transmission, and blocking calcium influx in neurons
View Patent ↗The present invention pertains to methods to promote outgrowth of, or extension across a substrate of, neuronal cells by inhibiting the interaction between the cytoplasmic tail of the L1-CAM cell surface adhesion molecule and the cytoskeletal protein ankyrin. The invention also pertains to a method to treat diseases characterized by axonal damage such as spinal cord injury, traumatic brain injury, stroke, and neurodegenerative disease by administration of novel peptides that inhibit the binding of the L1-CAM cytoplasmic tail to ankyrin, and to pharmaceutical compositions comprising such peptides. The invention further pertains to a method of blocking calcium flux to protect against neural cell death following stroke or traumatic head injury.
1. An isolated peptide derived from the ankyrin binding domain of an L1-CAM family member protein, wherein said peptide (i) does not contain transmembrane and extracellular portions of the L1-CAM family member protein, (ii) comprises the amino acid sequence of QFNEDGSFIGQF (SEQ ID NO: 2), and (iii) promotes neurite outgrowth.
2. The peptide of claim 1 comprising the amino acid sequence of QFNEDGSFIGQF (SEQ ID NO: 2) linked to the amino acid sequence of RQIKIWFQNRRMKWKK (SEQ ID NO: 6), wherein said sequences are linked by a disulfide bond.
3. A pharmaceutical composition comprising the peptide of claim 1 and a pharmaceutically acceptable carrier.
4. An isolated peptide consisting of the amino acid sequence of QFNEDGSFIGQF (SEQ ID NO: 2).
5. The peptide of claim 1 , which comprises a targeting sequence comprising the amino acid sequence of RQIKIWFQNRRMKWKK (SEQ ID NO: 6).
6. An isolated peptide consisting of the amino acid sequence of RQIKIWFQNRRMKWKKQFNEDGSFIGQF (SEQ ID NO: 3).
7. A method for promoting outgrowth of a mammalian neuron comprising contacting said neuron with the peptide of claim 1 .